Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Borel

Showing results (321-330 of 359) with videos related to

Pageof 36
Sort By:
Cancers|May 28, 2022
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide CohortKaren Bolhuis, G Emerens Wensink, Marloes A G Elferink, et al.
Neuroendocrinology|July 30, 2020
Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based CohortDirk-Jan van Beek, Helena M Verkooijen, Sjoerd Nell, et al.
Cancer Research|May 16, 2022
Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic StageMaria C Heinz, Niek A Peters, Koen C Oost, et al.
Annals of Surgical Oncology|September 26, 2024
Reclassification of Appendiceal Mucinous Neoplasms and Associated Pseudomyxoma Peritonei According to the Peritoneal Surface Oncology Group International Consensus: Clinicopathological Reflections of a Two-Center Cohort StudyPaulien Rauwerdink, Dania Al-Toma, Emma C E Wassenaar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 29, 2012
"Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients"B J van Wely, F J H van den Wildenberg, P Gobardhan, et al.
BMC Cancer|April 21, 2017
Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)I Ubink, H J Bloemendal, S G Elias, et al.
European Journal of Endocrinology|January 10, 2015
Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1Lutske Lodewijk, Pim J Bongers, Jakob W Kist, et al.
British Journal of Cancer|February 23, 2022
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacityJamila Laoukili, Alexander Constantinides, Emma C E Wassenaar, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study GroupCarolina R C Pieterman, Joanne M de Laat, Jos W R Twisk, et al.
Frontiers in Oncology|September 23, 2022
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept studyNiek A Peters, Alexander Constantinides, Inge Ubink, et al.
Pageof 36

Showing results (321-330 of 359) with videos related to

Sort By:
Pageof 36
Cancers|May 28, 2022
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide CohortKaren Bolhuis, G Emerens Wensink, Marloes A G Elferink, et al.
Neuroendocrinology|July 30, 2020
Reliability and Agreement of Radiological and Pathological Tumor Size in Patients with Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors: Results from a Population-Based CohortDirk-Jan van Beek, Helena M Verkooijen, Sjoerd Nell, et al.
Cancer Research|May 16, 2022
Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic StageMaria C Heinz, Niek A Peters, Koen C Oost, et al.
Annals of Surgical Oncology|September 26, 2024
Reclassification of Appendiceal Mucinous Neoplasms and Associated Pseudomyxoma Peritonei According to the Peritoneal Surface Oncology Group International Consensus: Clinicopathological Reflections of a Two-Center Cohort StudyPaulien Rauwerdink, Dania Al-Toma, Emma C E Wassenaar, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 29, 2012
"Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients"B J van Wely, F J H van den Wildenberg, P Gobardhan, et al.
BMC Cancer|April 21, 2017
Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)I Ubink, H J Bloemendal, S G Elias, et al.
European Journal of Endocrinology|January 10, 2015
Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1Lutske Lodewijk, Pim J Bongers, Jakob W Kist, et al.
British Journal of Cancer|February 23, 2022
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacityJamila Laoukili, Alexander Constantinides, Emma C E Wassenaar, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study GroupCarolina R C Pieterman, Joanne M de Laat, Jos W R Twisk, et al.
Frontiers in Oncology|September 23, 2022
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept studyNiek A Peters, Alexander Constantinides, Inge Ubink, et al.
Pageof 36